PET scan study of beta cell function in diabetes
Part of Hormones & metabolism clinical trials.
This study uses a special PET scan to measure how well insulin-producing cells (“beta cells”) in the pancreas are working in people with diabetes. It’s meant to help researchers understand diabetes biology and test whether the scan can reflect beta cell function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- You must be able to understand the study and sign informed consent
- Your hemoglobin must be at least 12 g/dl
- Your HbA1c must be 10% or lower (HbA1c shows your average blood sugar)
- You must not be pregnant or breastfeeding, and women who can become pregnant must use reliable birth control and agree to a pregnancy test
- You should not have several scan-related or health exclusions, like severe claustrophobia or certain heart, lung, kidney, liver, cancer, or recent major heart problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a special ultrasound scan can clearly picture the pancreas in people with type 1 diabetes and in non-diabetes control participants. It may help researchers better understand the pancreas in diabetes.
This Phase 2 study uses special PET/MRI imaging to better understand a cause of hyperinsulinemic low blood sugar and guide whether surgery may help. It may help doctors choose the safest plan to reduce severe episodes and protect the brain.
This trial uses a special PET scan (a 3D imaging test) to look for cancer cells that have GLP-1 receptors, a protein on some tumors. It aims to see if this scan can help find or monitor cancer.
This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.
This trial improves a special PET scan (a type of brain/body imaging) using 18F-DOPA, to better show how certain conditions behave in the body. If you or your child may have one of the listed conditions, the study may help your doctors get clearer scan results.
This study tests a new way to measure how the brain uses sugar (glucose) to see if the hormone glucagon affects it. It may help researchers understand how certain hormones work in the body.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.